Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
InflaRx NV (IFRX)
NASDAQ:IFRX
InflaRx (IFRX) Stock Price & Analysis
567 Followers
IFRX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.57 - $7.25
Previous Close$3.06
Volume214.08K
Average Volume (3M)175.60K
Market Cap
$170.76M
Enterprise ValueN/A
Total Cash (Recent Filing)€16.27M
Total Debt (Recent Filing)€1.36M
Price to Earnings (P/E)-4.9
Beta1.62
Next Earnings
Mar 21, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.62
Shares Outstanding54,115,530
10 Day Avg. Volume98,888
30 Day Avg. Volume175,603
Standard Deviation0.33
R-Squared0.03
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)4.32
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$9.00Price Target Upside210.34% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
InflaRx News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
IFRX FAQ
What was InflaRx NV’s price range in the past 12 months?
InflaRx NV lowest stock price was $1.57 and its highest was $7.25 in the past 12 months.
What is InflaRx NV’s market cap?
Currently, no data Available
When is InflaRx NV’s upcoming earnings report date?
InflaRx NV’s upcoming earnings report date is Mar 21, 2024 which is in 176 days.
How were InflaRx NV’s earnings last quarter?
InflaRx NV released its earnings results on Aug 10, 2023. The company reported -$0.148 earnings per share for the quarter, beating the consensus estimate of -$0.33 by $0.182.
Is InflaRx NV overvalued?
According to Wall Street analysts InflaRx NV’s price is currently Undervalued.
Does InflaRx NV pay dividends?
InflaRx NV does not currently pay dividends.
What is InflaRx NV’s EPS estimate?
InflaRx NV’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does InflaRx NV have?
InflaRx NV has 58,883,270 shares outstanding.
What happened to InflaRx NV’s price movement after its last earnings report?
InflaRx NV reported an EPS of -$0.148 in its last earnings report, beating expectations of -$0.33. Following the earnings report the stock price went up 9.589%.
Which hedge fund is a major shareholder of InflaRx NV?
Among the largest hedge funds holding InflaRx NV’s share is Woodline Partners LP. It holds InflaRx NV’s shares valued at 2M.
---
InflaRx Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$9.00 (210.34% Upside)
$9.00 (210.34% Upside)
Crowd Wisdom
Neutral
Last 7 Days ▲ 0.6%
Last 30 Days ▼ 1.1%
Last 30 Days ▼ 1.1%
Technicals
SMA
Positive
20 days / 200 days
Momentum
31.81%
12-Months-Change
Fundamentals
Return on Equity
-28.83%
Trailing 12-Months
Asset Growth
-26.76%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
InflaRx NV
InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a. Its products includes IFX-1 and IFX-2. The company was founded by Niels Christoph Riedemann, Renfeng Guo and Nicolas Fulpius in December 2007 and is headquartered in Jena, Germany.
---
Top 5 ETFs holding IFRX
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold IFRX. The ETFs are listed according to market value of IFRX within the ETF
---